Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: I read with interest Lawrence’s article about a 33-year-old male patient with migraine with aura who self-experimented with psilocybin for his migraine attacks, which
Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: Thank you for your interest in this case report1 and for your insightful comments. I appreciate the thoroughness of your feedback and concur with
Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: Emerging data on sex differences in the efficacy and tolerability of antipsychotics in patients with schizophrenia are not taken into account in current guidelines,
by Eirini Beneki, MSc, MD, PhD(c); Kyriakos Dimitriadis, MD, PhD; Elias Zintzaras, MD, PhD; Panagiotis Kostakis, MD, PhD(c); Constantina Aggeli, MD, PhD; and Konstantinos Tsioufis, MD, PhD Drs. Beneki, Dimitriadis,
by Terry Correll, DO; Julie Gentile, MD, MBA; and Andrew B. Correll, MD Dr. T. Correll is Clinical Professor, Department of Psychiatry, Wright State University Boonshoft School of Medicine in
by Ragaviveka Gopalan, BSc, MS; Himanshi Pande, BA; Saralya Narayanan, BSc; and Adith Chinnaswami, MS, MBBS Ms. Gopalan and Dr. Chinnaswami are with MediSim VR in Chennai, India. Ms. Pande
by Mohammad Ibrahim, MBBS; Hassam Nasir Khan Alizai, MBBS; Izma Shahid, MBBS; and Muhammad Hannan Malik, MBBS, MCPS All authors are with Shaikh Zayed Hospital, Lahore in Lahore, Punjab, Pakistan.
by Amro H. Mohammad, MD, PhD; Marie-Pier Lecours, MD, PhD; Emmanuel Adams-Gelinas, BSc; Arshia Kakkar, MD; and Anthi Stefatos, MD, FRCPC Dr. Mohammad, Mr. Adams-Gelinas, and Dr. Kakkar are with
by Denita Neal, JD Ms. Neal is Senior Risk Manager of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article.
Innov Clin Neurosci. 2024;21(10–12):8. Dear Editor: The interesting article by Zuckerberg et al1 on a 29-year-old male patient with schizophrenia, catatonia, and stupor associated with an enlarged cavum septum pellucidum
by Dr. Yousra Benmakhlouf, PhD; Dr. Achraf Laghmich, PhD*; Kaoutar Ben Makhlouf, PhD*; Prof. Amina Barakat, PhD; Prof. Naima Ghailani Nourouti, PhD; and Prof. Mohcine Bennani Mechita, PhD All authors
by Julie P. Gentile, MD, MBA, and Larrilyn Grant, MD, MS Drs. Gentile and Grant are with the Department of Psychiatry at Wright State University in Dayton, Ohio. Funding: No
by Marah Aymen Allen, BS, medical student; Danya Ansari, MBBS; and Sadiq Naveed, MD, MPH Ms. Allen is a medical student, University of New England College of Osteopathic Medicine in
by Eric Morse, MD; Graeme Christianson, BSE; Melissa Olivadoti, PhD; and John Timberlake, MBA Dr. Morse is with Carolina Performance in Raleigh, North Carolina and Morse Clinics in Raleigh, North
by Nitin Pothen, MD; Prachi Patel, BSN, MD; and Aneela Jafri, MD All authors are with Ocean University Medical Center in Brick, New Jersey. Funding: No funding was provided for
by Yetty Ramli, MD, SpN(K); Fadhlan Rusdi, MD, SpN; Mohammad Kurniawan, MD, SpN(K); Mohamad Sadikin, MD, DSc; and Florencia Evelyn, MD Drs. Ramli, Rusdi, Kurniawan, and Evelyn are with the
by Prof. Yuliarni Syafrita, Sp.N(K); Harnavi Harun, Sp.PD-KGH, FINASIM; Restu Susanti, Sp.S(K) M. Biomed; and Syarif Indra, Sp.N(K) Prof. Syafrita and Drs. Susanti Indra are with the Department of Neurology,
by Donna Vanderpool, MBA, JD Ms. Vanderpool is Director of Risk Management at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures:
A Message from the Editor Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with
Innov Clin Neurosci. 2024;21(7–9):8–9. Dear Editor: In the treatment of chronic pain of unknown cause, contradictions can arise; a drug for the treatment of a disease might be a cause
